Dr. Gina Agiostratidou is the Program Director for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program, which aims to advance research, treatments, technologies, and services that improve the lives of people with type 1 diabetes.
Previously, Gina was the scientific program manager at the Children’s Tumor Foundation, bringing scientists from around the globe together to collaborate on research opportunities in the field of neurofibromatosis. She completed two post-doctoral fellowships at Albert Einstein College of Medicine and Mount Sinai School of Medicine, focusing primarily on molecular biology and biochemistry.
Gina earned a Ph.D. in molecular biology from the Medical School, National and Capodistrian University of Athens, Greece, and a M.Sc. degree in advanced molecular biology and biotechnology at the University of London, UK. She also holds an M.B.A. from New York University’s Stern Business School.
- Op-Ed: Lessons from Diabetes Can Strengthen Global Care for People with NCDs
- T1D Program Director Gina Agiostratidou, PhD Joins “Progress, Potential, and Possibilities” Podcast
- T1D Program Director Gina Agiostratidou, PhD Interviewed by Grantee INNODIA
- T1D Program Director Gina Agiostratidou Discusses NCD Care in Health Policy Watch
- Gina Agiostratidou, PhD Quoted in Coverage of the Lancet NCDI Poverty Commission
- Non-Communicable Diseases and Injuries: Closing the Gap for the Poorest Billion